CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Traws Pharma, Inc.

TRAW
$7MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for TRAW. That does not mean none is planned.

Get an email about TRAW's next catalysts

Track Traws Pharma (TRAW) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

1 upcoming, 1 past

Phase 2
βœ“Positive

TRX-100 Phase 2 Est. Readout

December 2026~TRX-100105

Primary completion for TRX-100 trial (NCT07371650) in Influenza

Final Phase 2a results: ratutrelvir showed median time to sustained symptom resolution of 13.5 days vs 14.5 days for PAXLOVID, no viral rebound through Day 28, and fewer treatment-related adverse events (1 of 32 vs 4 of 30). No treatment-related AEs in the 30 PAXLOVID-ineligible subjects. TXM tablet bridging study met objectives; TXM toxicology retesting showed no mutagenic effect up to 500 mg/kg.

Source

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaNEWTOWN6 employees

Frequently asked questions

What is in Traws Pharma, Inc.'s drug pipeline?β†’

CatalystAlert tracks 8 drug candidates in Traws Pharma, Inc.'s (TRAW) pipeline across Phase 3, Phase 2. Its lead program is ON 01910.Na (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Traws Pharma, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Traws Pharma, Inc. (TRAW) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track TRAW biotech catalysts?β†’

Add TRAW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Traws Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply